Cargando…
Informed Consent for Phase I Oncology Trials: Form, Substance and Signature
BACKGROUND: Federal regulations state consent information should be understandable to participants; concerns have been voiced about the quality of informed consent forms (ICFs) in oncology trials. METHODS: The content of ICFs for phase I studies that were conducted at a tertiary care cancer center o...
Autores principales: | Malik, Laeeq, Mejia, Alex |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3985563/ https://www.ncbi.nlm.nih.gov/pubmed/24734147 http://dx.doi.org/10.14740/jocmr1803w |
Ejemplares similares
-
Advanced Thyroid Cancer Patients in Phase I Clinical Trials: Outcome Assessment and Literature Review
por: Malik, Laeeq, et al.
Publicado: (2014) -
Written Informed Consent for Participation in a Study and Reduction in Consent Rate
por: Tamakoshi, Akiko, et al.
Publicado: (2008) -
Phase I oncology trials incorporating patient choice of dose
por: Huson, L W
Publicado: (2012) -
The Complex Maze of the Informed Consent Process: Helping to Improve Comprehension in Clinical Trial Participants with Alzheimer’s Disease
por: Wong, Louis X., et al.
Publicado: (2020) -
Study protocol for a randomised controlled trial of enhanced informed consent compared to standard informed consent to improve patient understanding of early phase oncology clinical trials (CONSENT)
por: Pal, Abhijit, et al.
Publicado: (2021)